Pakistan joins 52 countries on Covid-19 research, development

Published August 27, 2021
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. —  AFP/File
WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study. — AFP/File

ISLAMABAD: Pakistan has enrolled to participate in the ‘Solidarity PLUS’ clinical trial led by the World Health Organisation (WHO) that will evaluate three potential drugs — artesunate, imatinib and infliximab — for the treatment of Covid-19 infections aiming to protect people from severe hospitalisation and death because of the pandemic.

WHO has announced that researchers and scientists from Egypt, Iran, Kuwait, Lebanon, Oman, Pakistan and Saudi Arabia are joining thousands of researchers in 52 countries worldwide in the study, making up the largest global collaboration on Covid-19 research and development.

The three potential drugs were selected by a panel of experts who assess all available evidence on relevant therapeutics. The drugs have proven effectiveness in treating other life-threatening diseases. Artesunate is used for severe malaria, imatinib for specific cancers, and infliximab for diseases of the immune system, such as Crohn’s disease and rheumatoid arthritis.

“Covid-19 has been the most disruptive public health challenge in the past century. In less than two years, the pandemic has claimed over 4.4 million lives across the world, overwhelmed health systems, and disrupted economies and societies.

“It is critical that we find effective treatments to prevent severe hospitalisation and death caused by Covid-19. We appreciate the efforts of countries in the region in collaborating on vital global studies for the treatment of Covid-19, in the spirit of solidarity,” said Dr Ahmed Al-Mandhari, WHO Regi­onal Director for the Eastern Mediterranean.

Published in Dawn, August 27th, 2021

Opinion

Editorial

Political sacrifice
Updated 30 Nov, 2023

Political sacrifice

Imran deserves praise for displaying political maturity in handling party's chairmanship transition.
‘Quick-fix’ nation
30 Nov, 2023

‘Quick-fix’ nation

THE impulse for policy prescriptions that will quickly ‘fix’ the rotten economy, create tens of hundreds of jobs...
Narcotics menace
30 Nov, 2023

Narcotics menace

WE are watching a tragedy unfold — the curse of substance abuse and addiction hits every fourth household in...
Sindh lawlessness
29 Nov, 2023

Sindh lawlessness

GOVERNMENTS come and go, but little has been done to control rampant crime across Sindh, particularly its lawless...
New compact
29 Nov, 2023

New compact

AS elections approach ever closer without any tangible improvement in the political atmosphere, there has been a...
Climate crossroads
Updated 29 Nov, 2023

Climate crossroads

As Pakistan presents its case at COP28, the focus must be on ensuring that the L&D fund.